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Analogues of S-prenylated cysteine like IV-acetyl-Struns,truns-farnesyl-L-cysteine (AFC) have previously been shown to inhibit the carboxyl 
methylation of proteins carrying a C-terminal Sprenylated cysteine residue and to block the endotoxin-activated serum-elicited chemotactic 
response of mouse macrophages. Here, we show that AFC inhibits both basal and formyl peptide receptor-stimulated binding of guanosine 
5’-0-(3-thiotriphosphate) (GTP[S]) to and hydrolysis of GTP by membranes of myeloid differentiated HL-60 granulocytes. Receptor-stimulated 
GTP[S] binding and GTP hydrolysis are more sensitive to AFC inhibition than basal G-protein functions. Inhibition of formyl peptide receptor- 
mediated G-protein activation is also observed for S-tram, trans-famesyl-3-thiopropionic acid, but not for N-acetyl-S-truns-geranyl-L-cysteine. 
N-acetyl-L-cysteine, or the methyl ester of AFC, suggesting that the famesyl moiety and the carboxyl group, but not the peptide bond of AFC are 
required for inhibition. The observations that exogeneous S-adenosyl-L-methionine is apparently not required for and S-adenosyl-L-homocysteme 
does not attenuate the inhibitory action of AFC raise the distinct possibility that AFC inhibits receptor-mediated G-protein interaction by a 
mechanism other than inhibition of protein carboxyl methylation. 
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1. INTRODUCTION 
Signal-transducing, heterotrimeric guanine nucleo- 
tide binding proteins (G-proteins) are involved in cou- 
pling an enormous variety of cell surface receptors to 
second messenger generating effector enzymes or ion 
channels [1,2]. G-Proteins are composed of three sub- 
units (a, /?, y), which are members of rapidly growing 
gene families [2]. To date, at least 20 distinct c1 subunits, 
four B subunits and six y subunits are known to exist 
in mammalian cells [2]. 
The y subunits of heterotrimeric G proteins belong 
to a family of proteins which are posttranslationally 
modified at their carboxyl-terminus by isoprenylation, 
proteolytic cleavage, and methyl esterification (see [3] 
for review). They are first farnesylated or geranylger- 
anylated at a cysteine in position -4 from the carboxyl 
terminus [3,4]. Following S-isosprenylation, a mem- 
brane-bound protease cleaves the three terminal 
amino acids [5,6] and the resultant terminal carboxyl 
group is methyl esterified by a membraneous meth- 
yltransferase [7]. It has been suggested that the methyl- 
ation reaction is the only reaction in this pathway which 
is reversible and subject to regulation [8,9]. The func- 
tional roles of these posttranslational y subunit modifi- 
cations remain unresolved. On the one hand, evidence 
has been presented suggesting that these modifications 
are important for membrane attachment of the /3y 
dimer [lo]. On the other hand, the fact that other simi- 
larly modified proteins are localized to specific cell 
membranes or remain soluble has prompted the hy- 
pothesis that the C-terminal modifications cause the 
association of these proteins with specific ‘receptor’ pro- 
teins present in these membranes or in the cytosol [3]. 
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The y subunit methyltransferase recognizes and 
methylates even small structural analogues of the S- 
prenylated y subunit C-terminus, such as N-acetyl-S- 
farnesyl-L-cysteine (AFC) [8,1 l-131. Recent evidence 
suggests that AFC competitively inhibits the carboxyl 
methylation of S-prenylated ~21”” and several small 
molecular mass GTP-binding proteins, including 
human platelet Rap1 [14] and human neutrophil Rap1 
and Rap2 [12]. Most interestingly, treatment of intact 
mouse macrophages with AFC in vivo caused a marked 
inhibition of their chemotactic response toward en- 
dotoxin-activated serum, but not to phorbol ester [12], 
suggesting that AFC interfered with a step in macro- 
phage signal transduction prior to protein kinase C ac- 
tivation. 
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We therefore set out to determine the effect of AFC 
on coupling of chemotactic peptide receptors to G-pro- 
teins using myeloid differentiated human HL-60 gran- 
ulocytes as a model system [151. While investigating the 
effects of treating intact HL-60 cells with AFC, we 
found that AFC interferes with the chemotactic peptide 
receptor-mediated activation of G-proteins even when 
added to HL-60 cell membranes. Our results suggest 
that inhibition of the receptor/G-protein interaction 
may be a mechanism by which AFC inhibits endotoxin- 
activated serum-dependent chemotaxis of macrophages 
[ 121, but indicate that this inhibition is unlikely to be due 
to inhibition of isoprenylated protein methyltrans- 
ferase. 
2. MATERIALS AND METHODS 
2.1. Materials 
N-Acetyl-L-cysteine and 3-mercaptopropionic acid were purchased 
from Fluka. Trans,trans-famesyl bromide and trans-geranyl bromide 
were from Aldrich. [r5S]GTP[S] and [y-rZP]GTP were obtained from 
New England Nuclear. All other materials were from standard ven- 
dors or from sources previously described [lS]. 
2.2. Synthesis of S-prenyl compounds 
AFC, AGC, FTP were prepared through incubation of either 
trans,trans-farnesylbromide or trans-geranylbromide with N-acetyl-L- 
cysteine or 3-mercaptopropionic acid according to a previously re- 
ported procedure [16]. The methyl ester AFCMe was obtained from 
the corresponding carboxylic acid by overnight reatment with 0.1 M 
methanolic-HCl at room temperature [17]. The isolated products pro- 
duced single spots by TLC. The physical properties and spectroscopic 
characteristics (‘H-NMR, “C-NMR and mass spectroscopy) of these 
compounds were consistent with those reported in the literature [13]. 
The S-prenyl-compounds were dissolved in DMSO. The final assay 
concentration of DMSO was 0.5% (v/v). 
2.3. Cell culture and membrane preparation 
HL-60 cells were grown in suspension culture and induced to differ- 
entiate into mature myeloid forms by cultivation in the presence of 
1.25% (v/v) dimethyl sulfoxide as described before [18]. Cells were 
homogenized by nitrogen cavitation and membranes were prepared as 
described (181. 
2.4. f’S]GTP[S] binding 
Binding of [‘5S]GTP[S] was assayed as described [151. In brief, mem- 
branes (34 pg protein) were incubated at 30°C in a mixture (100 ~1) 
containing 50 mM triethanolamine-HCI, pH 7.3, 1 mM dithiothreitol, 
1 mM EDTA, 5 mM MgClr, 150 mM NaCl, 1 ,uM GDP, and 0.2-0.4 
nM [35S]GTP[S] (1,200 Wmmol). The incubation was terminated by 
rapid filtration through 0.45 pm pore size nitrocellulose membranes 
(Advanced Microdevices, India). The membranes were washed and 
the retained radioactivity was determined by liquid-scintillation count- 
ing. Non-specific binding was defined as the binding not competed for 
by 50 PM unlabelled GTP[S]. Only specific binding is reported. 
2.5. GTPase assay 
Hydrolysis of [y-rrP]GTP was determined in a reaction mixture (100 
~1) containing 5 fig membrane protein, 50 mM triethanolamine-HCI, 
pH 7.3, 1 mM dithiothreitol, 1 mM EDTA, 5 mM MgCl,, 100 mM 
NaCl, 10 ,uM GDP, and 25 nM [y-‘2P]GTP (20 Ci/mmol). The reac- 
tions were terminated and the amount of [y-“P]GTP hydrolyzed was 
measured as described [18]. High-affinity GTPase activity was calcu- 
lated by subtracting low-affinity GTPase activity determined at 50,~M 
GTP from total GTPase activity. Only high-affinity GTPase activity 
is reported. 
3. RESULTS 
Fig. 1A shows the effect of AFC on the fMet-Leu- 
Phe-stimulated binding of [35S]GTP[S] to membranes of 
myeloid differentiated HL-60 cells. As reported before 
[ 151, fMet-Leu-Phe markedly stimulated the binding of 
[35S]GTP[S] in the absence of AFC. Half-maximal and 
maximal (approximately 4.5-fold) stimulation were ob- 
served at approximately 0.3 PM and 3 ,uM fMet-Leu- 
Phe, respectively. AFC (100 PM) led to a substantial 
(approximately 25-fold) decrease in the potency of 
IMet-Leu-Phe to stimulate [35S]GTP[S] binding. Specifi- 
cally, half-maximal stimulation was observed at ap- 
proximately 7.5 PM fMet-Leu-Phe in the presence of 
AFC. Although saturation of the effect of fMet-Leu- 
Phe on [35S]GTP[S] binding was not observed even at 
the highest concentration of the peptide (30 PM), ex- 
trapolation of the binding isotherm suggests that maxi- 
mal stimulation would require 2 100 yM fMet-Leu-Phe. 
The effect of increasing concentrations of AFC on 
basal and fMet-Leu-Phe-stimulated [35S]GTP[S] bind- 
ing is shown in Fig. 1 B. Two aspects of this experiment 
are significant. First, at concentrations of AFC c 100 
PM, basal [3’S]GTP[S] binding remained largely unal- 
tered, whereas fMet-Leu-Phe-stimulated binding was 
markedly reduced. Thus, the net increase in [35S]GTP[S] 
binding induced by addition of 0.1 PM fMet-Leu-Phe 
was reduced by approximately 60% at 50 ,uM AFC and 
was completely eliminated at approximately 100 ,uM 
AFC. Second, AFC markedly inhibited [35S]GTP[S] 
binding both in the presence and in the absence of the 
chemotactic peptide at concentrations > 100 PM and led 
to a complete suppression of specific [35S]GTP[S] bind- 
ing at approximately 500 ,uM. 
The specificity of the effect of AFC on receptor-stim- 
ulated [35S]GTP[S] binding was examined using three 
S-prenylated AFC-analogs (100 PM) (Fig. 2). AFC led 
to an only slight decrease in basal [3’S]GTP[S] binding, 
but fully suppressed the net increase of binding due to 
addition of fMet-Leu-Phe (0.1 PM). In contrast, 
AFCMe, the methyl ester of AFC, did not affect basal 
or fMet-Leu-Phe-stimulated [3’S]GTP[S] binding. Addi- 
tional experiments revealed that AFCMe was also with- 
out effect when tested over a wide range of concentra- 
tions up to 500 PM (results not shown). AGC, an ana- 
logue carrying a C,, geranyl instead of a C,, farnesyl 
moiety, did not interfere with [3sS]GTP[S] binding. In- 
terestingly, FTP, an AFC analogue lacking the acetyl 
amide moiety, reduced basal and fMet-Leu-Phe-stimu- 
lated [35S]GTP[S] binding by approximately 60% and 
70%, respectively, which resulted in a reduction by ap- 
proximately 85% in the net response caused by fMet- 
Leu-Phe. Additional experiments revealed that N-ace- 
tyl+cysteine (50 ,uM-500 ,uM) had no effect on basal 
or fMet-Leu-Phe-stimulated [35S]GTP[S] binding (re- 
sults not shown). Thus, the farnesyl moiety and the 
carboxyl group, but not the peptide bond of AFC are 
111 
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Fig. t . Effect of AFC on fMet-Leu-Phe-stimulated binding of [35S]GTP[S] to HL-60 cell membranes. (A) HL-60 cell membranes were mcubated 
in the absence (open symbols) or presence (closed symbols) of 100 ,uM AFC with [‘5S]GTP[S] and fMet-Leu-Phe at concentrations indicated at 
the abscissa. The incubation was carried out for 60 min at 30°C. The samples were analyzed for bound [‘%.]GTP[S] as described in section 2. (B) 
HL-60 cell membranes were incubated for 60 min in the absence (open symbols) or presence (closed symbols) of 100 nM fMet-Leu-Phe with 
[35S]GTP[S] and AFC at concentrations indicated at the abscissa. 
required for inhibition of receptor/G-protein interac- 
tion. 
Next, we investigated the effect of AFC on high- 
affinity GTPase activity of HL-60 membranes. Fig. 3A 
illustrates that fMet-Leu-Phe led to an about 2-fold 
stimulation of GTP hydrolysis in the absence of AFC. 
Half-maximal and maximal stimulation were observed 
at approximately 2 juM and 10 ,ffM fMet-Leu-Phe, re- 
spectively, AFC (100 PM) reduced GTPase activity by 
about 50% in the absence of fMet-Leu-Phe and by ap- 
proximately 45% in the presence of a maximally stimu- 
lating concentration of the chemotactic agonist (30 
PM). Thus, 100pM AFC caused a reduction by approx- 
imately 75% in the net fMet-Leu-Phe-dependent in- 
crease in GTP hydrolysis. Fig. 3B shows the inhibition 
of basal and jet-Leu-Phe-stimulated GTPase activity 
by increasing concentrations of AFC. Both basal and 
jet-Leu-Phe-stimulated GTP hydrolysis were reduced 
by 50% at approximately 100 PM AFC and were fully 
suppressed when AFC was present at concentrations 
2400 ,uM. 
4. DISCUSSION 
In the late 197Os, the well established regulatory role 
of protein carboxyl methylation in bacterial chemotaxis 
(reviewed in [3]) prompted investigators to determine 
the importance of this posttranslational modification in 
regulating the chemotaxis of eukaryocytes. Although 
early studies of this type suggested a close association 
of protein carboxyl methylation and leukocyte activa- 
tion [19,20], subsequent experimentation revealed that 
some of the effects initially observed were highly varia- 
ble and that experiments based on the use of general 
methylation inhibitors were more difficult to interpret 
than anticipated [21,22]. Interest in the potential role of 
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carboxyl methylation in regulating leukocyte activation 
revived only recently when it became clear that the y 
subunits of signal-transducing G-proteins are methyl 
esterified at their C-termini [3] and that farnesylcysteine 
analogues like AFC inhibit both carboxyl methylation 
of S-prenylated proteins and leukocyte chemotaxis [12]. 
At first glance, inhibition of y subunit methylation 
appears to be a likely explanation for the marked inhib- 
itory effects of AFC on basal and formyl peptide recep- 
tor-stimulated [“S]GTP[S] binding and [Y-~‘P]GTP hy- 
drolysis in HL-60 membranes reported here. However, 
the fact that this inhibition is observed in well washed 
membrane preparations, which should be devoid of the 
methyl transferase co-substrate S-adenosyl+-methion- 
ine, argues against such a mechanism. Furthermore, the 
r-- T 
Control AFC AFCMe AGC FTP 
Fig. 2. Effect of AFC-related S-prenyl compounds on basal and fh4et- 
Leu-Phe-stim~ated [%S]GTP[S] binding to HL-60 eel1 membranes. 
HL-60 cell membranes were incubated for 60 min m the absence fopen 
bars) or presence (hatched bars) of 0.1 ,uM fMet-Leu-Phe with 
[%]GTP[S] as described m section 2. The incubation was performed 
m the absence (Control) or presence of 100 PM of the S-prenyl com- 
pounds specified at the absctssa. 
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Fig. 3. Effect of AFC on fMet-Leu-Phe-stimulated GTP hydrolysis by HL-60 cell membranes. (A) High-affinity GTPase activity was determined 
by incubating HL-60 cell membranes for 15 min at 30°C in the absence (open symbols) or presence (closed symbols) of lOO.#M AFC with increasing 
con~ntrations of jet-Leu-Phe. See section 2 for experimental details. (B) High-a~nity GTPase activity of HL-40 cell membranes was dete~ined 
in the absence (open symbols) or presence (closed symbols) of 0.1 ,uM fMet-Leu-Phe at concentrations of AFC indicated at the abscissa. 
methyl transferase inhibitor S-adenosyl-L-homocys- 
teine [23] (1 ,uM-100 ,uM) had no effect on basal and 
Net-Leu-Phe-stimulated [35S]GTP[S] binding in this 
membrane preparation and AFC (100 ,uM) blocked the 
effect of fMet-Leu-Phe on f3’S]GTP[S] binding without 
delay (results not shown). Thus, the possibility has to 
be considered that AFC affects receptor/G-protein cou- 
pling by a mechanism distinct from inhibition of y sub- 
unit carboxyl methylation. 
Since AFC is an amphiphilic molecule possessing a 
hydrophobic farnesyl moiety and a hydrophilic car- 
boxy1 group, the inhibition of receptor/G-protein cou- 
pling by AFC could conceivably be due to a non-spe- 
cific, detergent-like property of this compound. We do, 
however, not feel that this is a likely possibility, at least 
not at concentrations up to 100 PM, since these concen- 
trations of AFC have previously been reported to have 
no effect on motility, morphology, viability, and the 
phorbol ester-induced chemotactic response of intact 
mouse macrophages [12]. Furthermore, the compound 
did not alter the incorporation of [35S]methionine into 
cultured transformed fibroblasts and had little effect on 
the proliferation of these cells [12]. 
It thus appears likely that AFC interferes the activa- 
tion of G-proteins by the agonist-activated formyl pep- 
tide receptor in a more specific fashion. The fact that 
AFC inhibits the activation of G-proteins by at least 
two other G-protein-coupled receptors (Scheer and Gi- 
erschik, in preparation) argues against the hypothesis 
that AFC inhibits the interaction of formyl peptides 
with their receptors. Of interest, a retinal /Iy subunit 
lacking the carboxyl terminal isoprenylated cysteine has 
previously been shown to support the pertussis toxin- 
mediated ADP-ribosylation of transducin 01 subunit 
only poorly [24,25]. These results indicated that the C- 
terminal y subunit modification may be essential for the 
formation of the cx;By heterotrimer, which is known to 
be required for receptor-mediated G-protein activation 
[26]. It is thus conceivable that AFC acts primarily as 
a competitive inhibitor of the a - By subunit interaction. 
Our finding that AFC also inhibited high-affinity bind- 
ing of the chemotactic agonist fMet-Leu-[3H]Phe to HL- 
60 cell membranes (results not shown) is consistent with 
this notion, since high affinity agonist binding to G- 
protein-coupled receptors is known to depend on the 
interaction of the holomeric G-protein with the receptor 
~271. 
On the other hand, very recent results obtained by 
analyzing the interaction of rhodopsin kinase and the 
&adrenergic receptor kinase with the corresponding re- 
ceptors are consistent with the notion that these recep- 
tors contain a ‘docking site’ for C-terminally isoprenyl- 
ated proteins [28,29]. These findings raise the intriguing 
possibility that AFC interferes with the receptor/G-pro- 
tein interaction by specifically blocking the docking of 
G-protein by subunits to receptors. At first glance, our 
finding that AFC also inhibited mastoparan-stimulated 
[35S]GTP[S] binding to HL-60 membranes (results not 
shown), appears to argue against such a mechanism, 
since mastoparan is believed to activate heterotrimeric 
G-proteins by directly interacting with the carboxyl- 
terminus of their c1 subunits [30], which are not isopren- 
ylated [31,32]. However, recent evidence suggests that 
mastoparan also interacts with the low molecular mass 
GTP-binding proteins rholrac [33]. Very interestingly, 
isoprenylation is a prerequisite for this interaction [34], 
suggesting that the isoprenylated carboxyl-termini of 
low molecular mass GTP-binding proteins - and possi- 
bly of G-protein y subunits - may interact with masto- 
paran as well, 
In any case, experiments examining the interaction of 
purified receptors and purified G-protein subunits in a 
113 
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reconstituted system will be required to decide whether 
AFC interacts with receptors, G-proteins or both. Not- 
withstanding the outcome of these studies, we speculate 
that AFC might not only turn out to be a novel type of 
inhibitor of the receptor/G-protein or G-protein subunit 
interaction, but might also represent he prototype of a 
new class of drugs acting at these early steps of trans- 
membrane signalling. 
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